Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine

Bone Marrow Transplantation

Volumn 18, Issue 4, 1996, Pages 741-746

  Mehta, J ^a   Powles, R ^a   Treleaven, J ^a   Horton, C ^a   Tait, D ^a   Meller, S ^a   Pinkerton, C R ^a   Middleton, G ^a   Eisen, T ^a   Singhal, S ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Acute myeloid leukemia; Cyclophosphamide; Cyclosporine; Graft versus host disease; Total body irradiation

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CAUSE OF DEATH; CHILD; DRUG TOXICITY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROBABILITY; RELAPSE; SIBLING; SURVIVAL; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; REMISSION INDUCTION; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 10244257536     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 292: 832-843, 895-902.
2. Thomas ED, Buckner CD, Clift RA et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. New Engl J Med 1979; 301: 597-599.
3. Powles RL, Barrett AJ, Clink H et al Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet 1978; 2: 1327-1331.
4. Powles RL, Clink HM, Spence D et al. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone marrow transplantation. Lancet 1980; 1: 327-329.
5. Powles RL, Morgenstern G, Clink HM et al. The place of bone marrow transplantation in acute myelogenous leukaemia. Lancet 1980; 1: 1047-1050.
6. Powles RL, Morgenstern GR, Kay HE et al. Mismatched family donors for bone marrow transplantation as treatment for acute leukaemia. Lancet 1983; 1: 612-615.
7. Chao NJ, Schmidt GM, Niland JC et al. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. New Engl J Med 1993; 329: 1225-1230.
8. Helenglass G, Powles RL, McElwain TJ et al. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission. Bone Marrow Transplant 1988; 3: 21-29.
9. Geller RB, Saral R, Piantadosi S et al. Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia. Blood 1989; 73: 2209-2218.
10. Clift RA, Buckner CD, Appelbaum FR et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood 1990; 76: 1867-1871.
11. Copelan EA, Biggs JC, Thompson JM et al. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood 1991; 78: 838-843.
12. Blaise D, Maraninchi D, Archimbaud E et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse. Blood 1992; 79: 2578-2582.
13. Snyder DS, Chao NJ, Amylon MD et al. Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood 1993; 82: 2920-2928.
14. Michel G, Gluckman E, Esperou Bourdeau H et al. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation - a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 1994; 12: 1217-1222.
15. Reiffers J, Gaspard MH, Maraninchi D et al. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial. Br J Haematol 1989; 72: 57-63.
16. Dahl GV, Kalwinsky DK, Mirro JJ et al. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute non-lymphocytic leukemia in first remission. J Clin Oncol 1990; 8: 295-303.
17. Cassileth PA, Lynch E, Hines JD et al. Varying intensity of postremission therapy in acute myeloid leukemia. Blood 1992; 79: 1924-1930.
18. Ringdén O, Horowitz MM, Sondel P et al. Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 1993; 81: 1094-1101.
19. Ljungman P, De Witte T, Verdonck L et al. Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing. Br J Haematol 1993; 84: 61-66.
20. Fagioli F, Bacigalupo A, Frassoni F et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis. Bone Marrow Transplant 1994; 13: 247-252.
21. Dini G, Boni L, Abla O et al. Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO). Bone Marrow Transplant 1994; 13: 771-776.
22. Gamberi B, Bandini G, Visani G et al. Acute myeloid leukemia from diagnosis to bone marrow transplantation: experience from a single centre. Bone Marrow Transplant 1994; 14: 69-72.
23. Weaver CH, Clift RA, Deeg HJ et al. Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia. Bone Marrow Transplant 1994; 14: 885-893.
24. Frassoni F, Labopin M, Gluckman E et al. Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia 1994; 8: 924-928.
25. Hewlett J, Kopecky KJ, Head D et al. A prospective evaluation of the roles of allogeneic marrow transplantation and low-dose monthly maintenance chemotherapy in the treatment of adult acute myelogenous leukemia (AML): a Southwest Oncology Group study. Leukemia 1995; 9: 562-569.
26. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. New Engl J Med 1995; 332: 217-223.
27. Powles R, Milan S, Horton C et al. A prospective haematooncology patient database: structure and description. Bone Marrow Transplant 1996; 17 (Suppl. 1): S140.
28. Powles R, Milan S, Horton C et al. A prospective haematooncology patient database for use in routine care and clinical research. Bone Marrow Transplant 1996; 17 (Suppl. 1): S55.
29. Mehta J, Powles R, Horton C et al. The relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. Bone Marrow Transplant 1995; 15: 853-858.
30. Powles R, Singhal S, Treleaven J et al. The first patients to have received cyclosporine for graft-versus-host disease prophylaxis after bone marrow transplantation: 15-year follow-up. Blood 1995; 86 (Suppl. 1): 394a.
31. Singhal S, Powles R, Treleaven J et al. Comparison of cell yields in a double-blind randomized study of allogeneic marrow versus blood stem cell transplantation. Br J Haematol 1996; 93 (Suppl. 1): 37.
32. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
33. Bacigalupo A, Piaggio G, Podesta M et al. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 221-226.
34. Bacigalupo A, Van Lint MT, Occhini D et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1988; 45: 1091-1094.
35. Kalaycioglu M, Copelan E, Avalos B et al. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide. Bone Marrow Transplant 1995; 15: 105-110.